65 related articles for article (PubMed ID: 24915432)
1. Incidence of hepatocellular carcinoma in Texas Latinos, 1995-2010: an update.
Ramirez AG; Munoz E; Holden AE; Adeigbe RT; Suarez L
PLoS One; 2014; 9(6):e99365. PubMed ID: 24915432
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
White DL; Thrift AP; Kanwal F; Davila J; El-Serag HB
Gastroenterology; 2017 Mar; 152(4):812-820.e5. PubMed ID: 27889576
[TBL] [Abstract][Full Text] [Related]
3. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.
Altekruse SF; Henley SJ; Cucinelli JE; McGlynn KA
Am J Gastroenterol; 2014 Apr; 109(4):542-53. PubMed ID: 24513805
[TBL] [Abstract][Full Text] [Related]
4. Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention.
Yang B; Liu JB; So SK; Han SS; Wang SS; Hertz A; Shariff-Marco S; Lin Gomez S; Rosenberg PS; Nguyen MH; Hsing AW
Cancer; 2018 Sep; 124(17):3551-3559. PubMed ID: 30113700
[TBL] [Abstract][Full Text] [Related]
5. Ambient ultraviolet radiation exposure and hepatocellular carcinoma incidence in the United States.
VoPham T; Bertrand KA; Yuan JM; Tamimi RM; Hart JE; Laden F
Environ Health; 2017 Aug; 16(1):89. PubMed ID: 28821245
[TBL] [Abstract][Full Text] [Related]
6. Neighborhood-Level Factors Contribute to Disparities in Hepatocellular Carcinoma Incidence in Texas.
Oluyomi AO; El-Serag HB; Olayode A; Thrift AP
Clin Gastroenterol Hepatol; 2023 May; 21(5):1314-1322.e5. PubMed ID: 35933074
[TBL] [Abstract][Full Text] [Related]
7. Hazardous air pollutants and primary liver cancer in Texas.
Cicalese L; Curcuru G; Montalbano M; Shirafkan A; Georgiadis J; Rastellini C
PLoS One; 2017; 12(10):e0185610. PubMed ID: 29016628
[TBL] [Abstract][Full Text] [Related]
8. Childhood cancer survival in the highly vulnerable population of South Texas: A cohort study.
Wu S; Liu Y; Williams M; Aguilar C; Ramirez AG; Mesa R; Tomlinson GE
PLoS One; 2023; 18(4):e0278354. PubMed ID: 37022991
[TBL] [Abstract][Full Text] [Related]
9. Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030.
Petrick JL; Kelly SP; Altekruse SF; McGlynn KA; Rosenberg PS
J Clin Oncol; 2016 May; 34(15):1787-94. PubMed ID: 27044939
[TBL] [Abstract][Full Text] [Related]
10. Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study.
Gosnell JM; Golovko G; Arroyave E; Moghe A; Kueht ML; Saldarriaga OA; McKinney KH; Stevenson HL; Ferguson MR
World J Diabetes; 2024 May; 15(5):886-897. PubMed ID: 38766421
[TBL] [Abstract][Full Text] [Related]
11. Community-Level Factors Associated with Hepatocellular Carcinoma Incidence and Mortality: An Observational Registry Study.
Mezzacappa C; Rossi R; Jaffe A; Taddei TH; Strazzabosco M
Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):270-278. PubMed ID: 38059831
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic differences and mortality among Latinos and non-Latino whites with gastric cancer at a majority-minority cancer center in South Texas.
Williams MH; Williams RA; Hernandez B; Michalek J; Long Parma D; Arora SP
J Gastrointest Oncol; 2021 Aug; 12(4):1301-1307. PubMed ID: 34532089
[TBL] [Abstract][Full Text] [Related]
13. Response to the Comments on Cicalese et al.: "An Ecological Study of the Association between Air Pollution and Hepatocellular Carcinoma Incidence in Texas".
Raun L; Shirafkan A; Campos L; Zorzi D; Montalbano M; Rhoads C; Gazis V; Ensor K; Rastellini C; Cicalese L
Liver Cancer; 2018 Sep; 7(3):301-303. PubMed ID: 30319990
[No Abstract] [Full Text] [Related]
14. Survival analysis of Hispanics in a cohort of patients with hepatocellular carcinoma.
Aparo S; Goel S; Lin D; Ohri N; Schwartz JM; Lo Y; Kaubisch A
Cancer; 2014 Dec; 120(23):3683-90. PubMed ID: 25081065
[TBL] [Abstract][Full Text] [Related]
15. STEAP2 promotes hepatocellular carcinoma progression via increased copper levels and stress-activated MAP kinase activity.
Torrez CZ; Easley A; Bouamar H; Zheng G; Gu X; Yang J; Chiu YC; Chen Y; Halff GA; Cigarroa FG; Sun LZ
Sci Rep; 2024 Jun; 14(1):12753. PubMed ID: 38830975
[TBL] [Abstract][Full Text] [Related]
16. "I don't want to look sick skinny": Perceptions of Body Image and Weight Loss in Hispanics Living with HIV in South Texas.
Abel JW; Allen O; Bullock D; Finley E; Walter EA; Schnarrs PW; Taylor BS
J Health Dispar Res Pract; 2018; 12(2):. PubMed ID: 38828271
[TBL] [Abstract][Full Text] [Related]
17. Understanding the Changing Landscape of Health Disparities in Chronic Liver Diseases and Liver Cancer.
Herren OM; Gillman AS; Marshall VJ; Das R
Gastro Hep Adv; 2023; 2(4):505-520. PubMed ID: 37347072
[TBL] [Abstract][Full Text] [Related]
18. Increase in aflatoxin exposure in two populations residing in East and West Texas, United States.
Xue KS; Tang L; Shen CL; Pollock BH; Guerra F; Phillips TD; Wang JS
Int J Hyg Environ Health; 2021 Jan; 231():113662. PubMed ID: 33197706
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States Cohort.
Pomenti S; Gandle C; Abu Sbeih H; Phipps M; Livanos A; Guo A; Yeh J; Burney H; Liu H; Dakhoul L; Kettler C; Gawrieh S; deLemos A; Scanga A; Chalasani N; Miller E; Wattacheril J
Hepatol Commun; 2020 Nov; 4(11):1708-1716. PubMed ID: 33163839
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of sorafenib in older adults with advanced hepatocellular carcinoma: An analysis of a majority Hispanic cohort.
Arora SP; Ananth S; Ketchum N; Gelfond J; Michalek J; Mahalingam D
J Geriatr Oncol; 2020 Sep; 11(7):1157-1160. PubMed ID: 32273248
[No Abstract] [Full Text] [Related]
[Next] [New Search]
